Relpax (eletriptan) for migraines

March 2003

Pfizer is now promoting Relpax (eletriptan) for migraines. It's the seventh triptan to hit the market.

Relpax 40 mg tablets seem to be at least as effective as oral Imitrex (sumatriptan)...and might have a faster onset.

The downside is drug interactions.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote